Patents by Inventor Nader Al Nakouzi

Nader Al Nakouzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostate cancer cell lines and their use in screening method
    Patent number: 8674172
    Abstract: The present invention relates to a prostate cancer cell line CNCM deposit number I-4126, the use thereof for preparing resistant prostate cancer cell lines, the resistant prostate cancer cell lines, and the use of these prostate cancer cell lines for screening compounds of interest.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: March 18, 2014
    Assignee: Institut Gustave Roussy
    Inventors: Anne Chauchereau, Karim Fizazi, Catherine Gaudin, Nader Al Nakouzi, Jean Benard
  • METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY
    Publication number: 20130130928
    Abstract: The present invention concerns in vitro methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family based on a resistance expression signature, kits for performing the methods, and methods for screening or identifying a compound suitable for improving the treatment of a cancer with a molecule of the taxoid family or for reducing the resistance development during the treatment of a cancer with the molecule of the taxoid family.
    Type: Application
    Filed: April 8, 2011
    Publication date: May 23, 2013
    Applicant: INSTITUT GUSTAVE ROUSSY
    Inventors: Anne Chauchereau, Frederic Commo, Nader Al Nakouzi
  • PROSTATE CANCER CELL LINES AND THEIR USE IN SCREENING METHOD
    Publication number: 20120036587
    Abstract: The present invention relates to a prostate cancer cell line CNCM deposit number I-4126, the use thereof for preparing resistant prostate cancer cell lines, the resistant prostate cancer cell lines, and the use of these prostate cancer cell lines for screening compounds of interest.
    Type: Application
    Filed: April 12, 2010
    Publication date: February 9, 2012
    Applicant: Institut Gustave Roussy
    Inventors: Anne Chauchereau, Karim Fizazi, Catherine Gaudin, Nader Al Nakouzi, Jean Benard
  • METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILY
    Publication number: 20110177970
    Abstract: The present invention concerns in vitro methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family based on a resistance expression signature, kits for performing the methods, and methods for screening or identifying a compound suitable for improving the treatment of a cancer with a molecule of the taxoid family or for reducing the resistance development during the treatment of a cancer with the molecule of the taxoid family.
    Type: Application
    Filed: October 2, 2009
    Publication date: July 21, 2011
    Applicants: Inserm (Institut National de la Sante et de la Recherche Medicale), Institut Gustave Roussy
    Inventors: Anne Chauchereau, Nader Al Nakouzi